The Relationship Between Vitamin D, Metabolic Dysfunction-Associated Steatotic Liver Disease, and Type 2 Diabetes: A Comprehensive Review of Global Insights and Perspectives for Sub-Saharan Africa - Report - MDSpire

The Relationship Between Vitamin D, Metabolic Dysfunction-Associated Steatotic Liver Disease, and Type 2 Diabetes: A Comprehensive Review of Global Insights and Perspectives for Sub-Saharan Africa

  • By

  • Bruno Basil

  • March 11, 2026

  • 0 min

Share

Clinical Report: Vitamin D, MASLD, and Type 2 Diabetes in Sub-Saharan Africa

Overview

This review highlights the link between Vitamin D deficiency, metabolic dysfunction-associated steatotic liver disease (MASLD), and Type 2 Diabetes Mellitus (T2DM) in Sub-Saharan Africa. It emphasizes the need for region-specific research and public health interventions to address these intertwined health issues.

Background

Metabolic dysfunction-associated steatotic liver disease (MASLD) and Type 2 Diabetes Mellitus (T2DM) are rising health concerns in Sub-Saharan Africa, exacerbated by urbanization and dietary changes. Understanding the role of Vitamin D deficiency in these conditions is crucial, as it may serve as a modifiable risk factor in a region facing unique health challenges.

Data Highlights

No numerical data available in the source material.

Key Findings

  • Vitamin D deficiency is linked to increased liver fibrosis and insulin resistance.
  • Mechanistic studies show Vitamin D has anti-inflammatory and insulin-sensitizing effects via VDR activation.
  • The “Vitamin D Paradox” in SSA presents unique challenges in defining deficiency.
  • Randomized controlled trials on Vitamin D's effects yield conflicting results due to dosing and baseline variations.
  • Future research should focus on ancestry-specific Vitamin D reference ranges in SSA.

Clinical Implications

Healthcare professionals should consider Vitamin D status in patients with MASLD and T2DM, particularly in Sub-Saharan Africa. Public health strategies may need to include Vitamin D fortification and tailored interventions to address the region's unique metabolic health landscape.

Conclusion

Vitamin D deficiency may significantly influence the MASLD-T2DM relationship in Sub-Saharan Africa, necessitating further research and targeted public health initiatives.

References

  1. Frontiers in Endocrinology, 2026 -- Childhood and Adolescent Metabolic-Associated Steatotic Liver Disease: A Comprehensive Review of Epidemiology, Risk Factors, and Screening Strategies with Focus on Sub-Saharan Africa
  2. The Journal of Clinical Endocrinology & Metabolism -- The Alarming Connection Between Vitamin D Deficiency and Type 2 Diabetes: Insights into Two Contemporary Health Crises
  3. Frontiers in Endocrinology, 2026 -- Investigation of Vitamin D Metabolism and Its Role in Disease Development
  4. The American Diabetes Association Releases “Standards of Care in Diabetes—2026” | American Diabetes Association
  5. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis - PubMed
  6. Frontiers in Endocrinology — Type 5 Diabetes Mellitus: Nutritional Impact on β-Cell Function, Diagnostic Challenges, and New Treatment Approaches
  7. The American Diabetes Association Releases “Standards of Care in Diabetes—2026” | American Diabetes Association
  8. Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated Steatohepatitis - PubMed
  9. Association between vitamin D and metabolic-associated steatotic liver disease in type 2 diabetes mellitus patients: a systematic review and meta-analysis - PMC

Original Source(s)

Related Content